RA
OGN icon

Rise Advisors’s Organon & Co OGN Stock Holding History

Rise Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-186
Closed -$1.99K – 1017
2025
Q3 		$1.99K Hold
186
– – ﹤0.01% 1192
2025
Q2 		$1.8K Buy
186
+53
+40% +$547 ﹤0.01% 1205
2025
Q1 		$1.99K Buy
133
+63
+90% +$969 ﹤0.01% 1180
2024
Q4 		$1.04K Sell
70
-331
-83% -$5.39K ﹤0.01% 1083
2024
Q3 		$7.67K Sell
401
-10
-2% -$207 ﹤0.01% 1048
2024
Q2 		$8.5K Buy
411
+20
+5% +$397 ﹤0.01% 1042
2024
Q1 		$7.35K Buy
391
+323
+475% +$5.54K ﹤0.01% 1069
2023
Q4 		$976 Buy
68
+1
+1% +$14 ﹤0.01% 522
2023
Q3 		$1.16K Sell
67
-194
-74% -$4.04K ﹤0.01% 521
2023
Q2 		$5.44K Sell
261
-5
-2% -$109 ﹤0.01% 415
2023
Q1 		$6.26K Hold
266
– – ﹤0.01% 425
2022
Q4 		$7.43K Hold
266
– – 0.01% 394
2022
Q3 		$6K Buy
266
+1
+0.4% +$30 0.01% 416
2022
Q2 		$9K Hold
265
– – 0.01% 355
2022
Q1 		$9K Sell
265
-1
-0.4% -$34 0.01% 349
2021
Q4 		$8.09K Buy
+266
New +$8.66K 0.01% 346

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Rise Advisors's OGN Position: Q4 2025 in Review

Rise Advisors sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 186 shares — an estimated $1.99K sold.

Rise Advisors first reported a position in OGN in Q4 2021 and held it in 16 quarters. The position peaked at $9K in Q2 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Rise Advisors reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 186 Organon & Co shares in Q4 2025, an estimated $1.99K.
  • Rise Advisors first reported a position in Organon & Co in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Organon & Co position peaked at $9K in Q2 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.